This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Microcap Article: Archive
Twin Disc Climbs 70% in 6 Months: Should You Buy the Stock?
by Zacks Equity Research
TWIN gains from rising defense spending, growing demand for hybrid systems, strategic acquisitions and strong financials, driving growth, innovation and long-term resilience.
FLSPositive Net Change NDSNPositive Net Change TWINPositive Net Change
industrial-products
Hurco Stock Gains Following Q3 Earnings Showing Narrower Losses
by Zacks Equity Research
HURC reports a narrower third-quarter fiscal 2025 loss and stronger revenues, fueled by solid demand in the Americas and Asia Pacific.
HURCNegative Net Change
earnings industrial-products
FONAR's Stock Advances 5% in Three Months: Key Trends Ahead
by Zacks Equity Research
FONR leverages hybrid MRI tech and a strong balance sheet to navigate industry headwinds, though rising costs and regulatory risks tied to claim collections remain key challenges.
FONRNegative Net Change ICCCPositive Net Change UGNegative Net Change
medical medical-devices
Comstock Soars 74% in 3 Months: What's Driving the Rally?
by Zacks Equity Research
CHCI drives growth with recurring fee revenues, rising parking demand, and robust transit-oriented projects, delivering scalable profits with a debt-free balance sheet.
KBHPositive Net Change MTHPositive Net Change CHCIPositive Net Change
construction
2 Small-Cap Emergency Response Stocks
by Mark Zinski
BKTI and BAER both operate in the Emergency Response space but with different products and business models.
BAERPositive Net Change
auto-tires-trucks communications
SIFCO Stock Surges 101.1% in Three Months: What's Fueling the Rally?
by Zacks Equity Research
SIF benefits from strong aerospace demand, cost cuts and operational efficiency to drive profitability and resilience, though supply risks remain key challenges.
PKEPositive Net Change SIFNegative Net Change OPXSNegative Net Change
aerospace defense
Koss Incurs a Wider Y/Y Loss in Q4 Due to Tariff Headwinds
by Zacks Equity Research
Newly imposed tariffs and weak U.S. demand lead to a wider year-over-year loss in Q4 for KOSS, though stronger export and DTC sales help partially offset the impact.
KOSSPositive Net Change
consumer-discretionary earnings
KTCC Gains 5.3% Despite Posting Wider Q4 Loss Amid Tariff Pressures
by Zacks Equity Research
Key Tronic posts wider y/y loss in Q4 on weaker demand. But cost cuts, new contracts and U.S.-Vietnam expansion boost long-term growth outlook.
KTCCPositive Net Change
earnings tech-stocks
Twin Disc Stock Soars 44% Despite Q2 Earnings Fall Y/Y on Higher Costs
by Zacks Equity Research
TWIN's Q4 earnings decline year over year on higher costs, but sales rose 15%. Backlog strength, acquisitions and electrification initiatives support its long-term growth outlook.
TWINPositive Net Change
earnings industrial-products
Cato's Q2 Earnings Jump Y/Y on Same-Store Sales Growth
by Zacks Equity Research
CATO delivers strong year-over-year earnings growth in Q2, fueled by higher same-store sales and cost discipline, while cautioning on tariff-related risks ahead.
CATONegative Net Change
earnings retail
La Rosa Jumps 12.9% on Y/Y Earnings Rise in Q2 From One-Time Gains
by Zacks Equity Research
LRHC posts y/y revenue growth and one-time gains driving profit in Q2, but rising costs and ongoing losses highlight challenges ahead.
LRHCNo Net Change
earnings multi-sector-conglomerates
PrimeEnergy Q2 Earnings Fall Y/Y on Lower Oil Prices, Stock Declines
by Zacks Equity Research
PNRG's Q2 revenues and earnings plunge y/y on weaker oil prices, while higher gas and NGL volumes, cost cuts and buybacks helped cushion the results.
PNRGPositive Net Change
earnings energy oil-energy
AXIL Stock Falls After Posting FY25 Results Despite Y/Y EBITDA Growth
by Zacks Equity Research
AXIL Brands stock slips post-FY25 results as revenues and EPS decline, but EBITDA, cash flow and a new wholesale deal boost long-term growth prospects.
AXILPositive Net Change
consumer-staples earnings
JSDA Posts Q2 Profit From Cannabis Sale Despite Y/Y Revenue Dip
by Zacks Equity Research
Jones Soda posts Q2 profit from cannabis sale despite a y/y revenue drop, with product launches and retail expansion aimed at fueling growth.
JSDANegative Net Change
consumer-staples earnings
Taylor Devices' Q4 Earnings Surge Y/Y on Defense Demand
by Zacks Equity Research
TAYD delivers record fiscal fourth-quarter results, as strong Aerospace/Defense demand led to a year-over-year increase in earnings despite challenges in Structural markets.
TAYDPositive Net Change
earnings industrial-products
AgEagle Stock Sinks 6.3% Despite Strong Y/Y Earnings Turnaround in Q2
by Zacks Equity Research
UAVS posts strong Q2 revenues and profit growth, but the stock plunges as investors question sustainability and market volatility.
UAVSPositive Net Change
consumer-staples earnings
Blue Dolphin Q2 Loss Narrows Y/Y, Stock Price Decreases 18%
by Zacks Equity Research
BDCO Q2 loss narrows y/y and improved margins, but revenues fell and shares drop 18% as market pressures weighed on investor sentiment.
BDCONegative Net Change
earnings energy oil-energy
ELTP Stock Gains Following Q1 Earnings Showing Strong Revenue Growth
by Zacks Equity Research
Elite Pharmaceuticals reports strong first-quarter fiscal 2026 results with rising direct sales, higher-margin products and expanding gross profit.
ELTPNegative Net Change
earnings medical
Vaso Stock Down Following Q2 Earnings as Revenue and Margins Fall
by Zacks Equity Research
VASO reports a second-quarter 2025 loss as lower imaging deliveries and rising costs pressured revenue and profit margins.
VASONegative Net Change
earnings medical medical-devices
BIAF Stock Down Following Q2 Earnings Despite CyPath Lung Growth
by Zacks Equity Research
bioAffinity shifts its focus on CyPath Lung as the second-quarter 2025 loss widens, with rising adoption and new market expansion underway.
BIAFPositive Net Change
earnings medical medical-devices
SIFCO Stock Up on Robust Q3 Earnings Recovery and Margin Expansion
by Zacks Equity Research
SIF returns to profitability in third-quarter fiscal 2025 as strong aerospace demand and cost cuts lifted margins and earnings.
SIFNegative Net Change
aerospace defense earnings
Retractable Technologies Stock Gains Following Q2 Earnings Growth
by Zacks Equity Research
RVP reports stronger second-quarter 2025 sales and narrows losses as domestic output offsets tariff headwinds.
RVPNegative Net Change
earnings medical medical-devices
ImmuCell Swings to Q2 Profit on Strong Sales, Shares Still Slide
by Zacks Equity Research
ICCC posts Q2 profit on higher sales and margins, but shares fall as investors weigh one-time boosts and Re-Tain's delayed commercialization.
ICCCPositive Net Change
earnings medical
ClearOne Stock Falls on Wider Q2 Loss, Revenue Decline and Sale Plan
by Zacks Equity Research
CLRO posts a wider Q2 loss on revenue decline, rising costs and supply issues as it pursues an asset sale to address ongoing risks.
CLRONegative Net Change
earnings tech-stocks
Onfolio Q2 Revenues Soar 83% but Losses Persist, Shares Drop
by Zacks Equity Research
ONFO's Q2 revenues jump 83% with narrower losses, but shares tumble as investors weigh new ventures, cost cuts and the path to profitability.
ONFOPositive Net Change
earnings retail